ResMed's Moat Is Underpinned by Switching Costs and Intangible Brand Assets
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
Sleep Software Market to Hit USD 1,569.2 Million by 2030 with 10.1% CAGR | MarketsandMarkets™
The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...
Listed drug development sector has several promising stories to tell this year
It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...